TD Waterhouse Canada
CSCI

TD Waterhouse Canada’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

TD Waterhouse Canada’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,860
Closed -$10.2K – 2189
2025
Q3 		$10.2K Hold
3,860
– – ﹤0.01% 1545
2025
Q2 		$13.2K Buy
3,860
+143
+4% +$475 ﹤0.01% 1396
2025
Q1 		$10.7K Hold
3,717
– – ﹤0.01% 1388
2024
Q4 		$9.94K Hold
3,717
– – ﹤0.01% 1413
2024
Q3 		$13.8K Hold
3,717
– – ﹤0.01% 1295
2024
Q2 		$17.6K Buy
+3,717
New +$28.3K ﹤0.01% 1240

TD Waterhouse Canada's CSCI Position: Q4 2025 in Review

TD Waterhouse Canada sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2025, closing a stake of 3,860 shares — an estimated $10.2K sold.

TD Waterhouse Canada first reported a position in CSCI in Q2 2024 and held it in 6 quarters. The position peaked at $17.6K in Q2 2024. 0 funds tracked by Wall St. Rank hold CSCI as of Q4 2025.

  • TD Waterhouse Canada reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 3,860 COSCIENS Biopharma Inc. Common Stock shares in Q4 2025, an estimated $10.2K.
  • TD Waterhouse Canada first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2024 and held it in 6 quarters.
  • TD Waterhouse Canada's COSCIENS Biopharma Inc. Common Stock position peaked at $17.6K in Q2 2024.
  • 0 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.